Bottom line
GTHIX vs FHLC: the short answer
GTHIX (INVESCO Health Care Fund) and FHLC (Fidelity MSCI Health Care Index ETF) are both mutual funds.
But FHLC is far broader, holding 337 positions to 82 for GTHIX, so beyond the top names it adds exposure GTHIX doesn't have.
FHLC is cheaper at 0.084% vs 1.07% — a difference of $99 a year per $10,000 invested.
Over five years, FHLC returned +7.2% a year vs +3.7% for GTHIX (reporting dates differ).
Updated Nov 19, 2026
GTHIX vs FHLC side by side
| GTHIX | FHLC | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Invesco | Fidelity |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.07% | 0.084% |
| Annual cost per $10k | $107 | $8.4 |
| 10-yr cost on $10k (prospectus) | $1,306 | $108 |
| Max front load | 0% | None |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +15.5% | +2.6% |
| 5-yr return (annualized) | +3.7% | +7.2% |
| 10-yr return (annualized) | +6.4% | +8.8% |
| Best quarter | +19.6% | +16.4% |
| Worst quarter | −16.5% | −13.1% |
| Net assets (fund) | $1.2B | $3.3B |
| Number of holdings | 82 | 337 |
| Portfolio turnover | 59% | 3% |
| Returns as of | Dec 31, 2025 | Nov 30, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
10 of GTHIX's top 25 holdings also appear in FHLC's top 25.
| Holding | GTHIX | FHLC |
|---|---|---|
| Eli Lilly and Co. | 10.59% | 13.35% |
| Johnson & Johnson | 6.76% | 8.93% |
| UnitedHealth Group Inc. | 6.17% | 5.44% |
| Merck & Co., Inc. | 4.59% | 4.66% |
| AbbVie Inc. | 4.03% | 6.42% |
| Gilead Sciences, Inc. | 3.63% | 2.34% |
| CVS Health Corp. | 2.52% | 1.92% |
| Cardinal Health, Inc. | 2.10% | 0.78% |
| Vertex Pharmaceuticals Inc. | 2.01% | 1.76% |
| Thermo Fisher Scientific Inc. | 1.55% | 3.09% |
Source: SEC Form N-PORT
GTHIX top 10
- Eli Lilly and Co. — 10.59%
- Johnson & Johnson — 6.76%
- UnitedHealth Group Inc. — 6.17%
- Invesco Private Prime Fund — 4.67%
- Merck & Co., Inc. — 4.59%
- AbbVie Inc. — 4.03%
- Gilead Sciences, Inc. — 3.63%
- argenx SE — 3.24%
- CVS Health Corp. — 2.52%
- Welltower Inc. — 2.34%
FHLC top 10
- Eli Lilly & Co — 13.35%
- Johnson & Johnson — 8.93%
- AbbVie Inc — 6.42%
- UnitedHealth Group Inc — 5.44%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 3.09%
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Gilead Sciences Inc — 2.34%
- Pfizer Inc — 2.06%
FAQ
What is the difference between GTHIX and FHLC?
Which is cheaper, GTHIX or FHLC?
Should I own both GTHIX and FHLC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.